Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Tenecteplase (Primary) ; Alteplase
- Indications Stroke
- Focus Therapeutic Use
- Acronyms EXTEND-IA TNK
- 15 Nov 2017 Planned End Date changed from 1 Dec 2018 to 1 Feb 2018.
- 15 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Apr 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.